By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its 2009 fourth-quarter revenues increased by 35 percent over Q4 2008, while revenue for the full year was up 16 percent over 2008.

The company reported total revenues of $38.2 million for the quarter ended Dec. 31, 2009, compared to $28.2 million for Q4 2008. Its Technology Group had revenues of $24.8 million compared to $22.1 million, and its Assay Group had revenues of $13.4 million versus $6.1 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.